The editor of Drug Discovery World, Reece Armstrong,  speaks to Michael Wyand, CEO  of Oxeia about the development of the company’s treatment for concussion (OXE103) and the current lack of effective therapies for #brain injuries.

https://www.ddw-online.com/qa-developments-in-concussion-therapies-29643-202405/